Pericardial effusion and cardiac tamponade in pediatric stem cell transplant recipients

Bone Marrow Transplantation

Volumn 36, Issue 2, 2005, Pages 139-144

  Rhodes, M ^a   Lautz, T ^a   Kavanaugh Mchugh, A ^a   Manes, B ^a   Calder, C ^a   Koyama, T ^b   Liske, M ^a   Parra, D ^a   Frangoul, Haydar ^a,b  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Effusion; Pediatric; Tamponade

Indexed keywords

BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; IDARUBICIN; MELPHALAN; MITOXANTRONE; PREDNISONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DEATH; ENTEROBACTER CLOACAE; FEMALE; FENESTRATION; GRAFT SURVIVAL; HEART FUNCTION; HEART TAMPONADE; HODGKIN DISEASE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MYELODYSPLASTIC SYNDROME; NEUROBLASTOMA; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDIOTOMY; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

ADOLESCENT; CARDIAC TAMPONADE; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; INFANT; MALE; PERICARDIAL EFFUSION; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 22844447023     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705023     Document Type: Article

References (22)

1. Hertenstein B, Stefanic M, Schmeiser T et al. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol 1994; 12: 998-1004.
2. Murdych T, Weisdorf DJ. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplant 2001; 28: 283-287.
3. Angelucci E, Mariotti E, Lucarelli G et al. Sudden cardiac tamponade after chemotherapy for marrow transplantation in thalassaemia. Lancet 1992; 339: 287-289.
4. Appelbaum F, Strauchen JA, Graw Jr RG et al. Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity. Lancet 1976; 1: 58-62.
5. Steinherz LJ, Steinherz PG, Mangiacasale D et al. Cardiac changes with cyclophosphamide. Med Pediatr Oncol 1981; 9: 417-422.
6. Gottdiener JS, Appelbaum FR, Ferrans VJ et al. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 1981; 141: 758-763.
7. Von Hoff DD, Rozencweig M, Layard M et al. Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases. Am J Med 1977; 62: 200-208.
8. Veys PA, McAvinchey R, Rothman MT et al. Pericardial effusion following conditioning for bone marrow transplantation in acute leukaemia. Bone Marrow Transplant 1987; 2: 213-216.
9. Saunders EF, Olivieri N, Freedman MH. Unexpected complications after bone marrow transplantation in transfusion-dependent children. Bone Marrow Transplant 1993; 12 (Suppl. 1): 88-90.
10. Pihkala J, Saarinen UM, Lundstrom U et al. Effects of bone marrow transplantation on myocardial function in children. Bone Marrow Transplant 1994; 13: 149-155.
11. Seber A, Khan SP, Kersey JH. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease. Bone Marrow Transplant 1996; 17: 207-211.
12. Toren A, Nagler A. Massive pericardial effusion complicating the course of chronic graft-versus-host disease (cGVHD) in a child with acute lymphoblastic leukemia following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 20: 805-807.
13. Ueda T, Manabe A, Kikuchi A et al. Massive pericardial and pleural effusion with anasarca following allogeneic bone marrow transplantation. Int J Hematol 2000; 71: 394-397.
14. Crossley RJ. Clinical safety and tolerance of mitoxantrone. Semin Oncol 1984; 11 (Suppl. 1): 54-58.
15. Chandraratna PA. Echocardiography and Doppler ultrasound in the evaluation of pericardial disease. Circulation 1991; 84 (Suppl. I): I-303-I-310.
16. Angelucci E, Mariotti E, Lucarelli G et al. Cardiac tamponade in thalassernia. Bone Marrow Transplant 1994; 13: 827-829.
17. Bearman SI, Petersen FB, Schor RA et al. Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity. Bone Marrow Transplant 1990; 5: 173-177.
18. Brockstein BE, Smiley C, Al-Sadir J et al. Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors. Bone Marrow Transplant 2000; 25: 885-894.
19. Silberstein L, Davies A, Kelsey S et al. Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusion. Bone Marrow Transplant 2001; 27: 231-233.
20. Cereda M, Trocino G, Pogliani EM, Schiavina R. A case of cardiac localization of graft-versus-host disease after allogenic bone marrow transplantation. Ital Heart J 2003; 4: 60-63.
21. Bunker CB, Sheron N, Maurice PD et al. Isotretinoin and eosinophilic pleural effusion. Lancet 1989; 1: 435-436.
22. Milleron BJ, Valcke J, Akoun GM, Mayaud CM. Isotretinoin-related eosinophilic pleural effusion. Chest 1996; 110: 1128.